Target intelligence / Profile preview

Lipopolysaccharide lipid A phosphate groups

Molecular classification
Other (Bacterial cell wall component), Glycolipid component
01

Overview

Lipid A phosphate groups are essential anionic components of the lipopolysaccharide (LPS) molecule found in the outer membrane of Gram-negative bacteria (Raetz et al., 2007, PubMed: 17589885). These phosphate groups, typically located at the 1 and 4' positions of the glucosamine backbone, provide a negative charge that is crucial for stabilizing the outer membrane through the bridging of divalent cations like calcium and magnesium (Nikaido, 2003, PubMed: 12730534). Biologically, they are recognized by the TLR4/MD-2 receptor complex in humans, triggering a potent inflammatory response that can lead to sepsis and septic shock (Park et al., 2009, PubMed: 19915566). From a therapeutic perspective, these phosphate groups serve as the primary binding site for cationic antimicrobial peptides and polymyxin antibiotics, such as colistin and polymyxin B (Velkov et al., 2013, PubMed: 24122106). Drugs target these groups via electrostatic interactions, which displaces stabilizing cations and leads to membrane disruption and bacterial cell death (Trimble et al., 2016, PubMed: 27530111). However, bacteria can develop resistance by modifying these phosphate groups with moieties like phosphoethanolamine or 4-amino-4-deoxy-L-arabinose, reducing the overall negative charge and drug affinity (Liu et al., 2016, PubMed: 26603172). This target is also a focus for the development of endotoxin-neutralizing agents designed to treat sepsis by preventing LPS from binding to host receptors (Matsuura, 2013, PubMed: 23435152).

Other names
Lipid A phosphateLPS phosphate groups1-phosphate and 4'-phosphate of lipid A
02

Mechanism of action

Electrostatic binding to negatively charged phosphate groups, displacing divalent cations and disrupting the bacterial outer membrane.

03

Biological functions

Immune responseOther (Outer membrane stabilization)Other (Endotoxic activity)
04

Disease associations

InfectionInflammationOther (Sepsis)
05

Safety considerations

NephrotoxicityNeurotoxicityBacterial resistance via phosphate modification
06

Interacting drugs

Polymyxin B

1 more in the full profile.

07

Biomarkers

Endotoxin levelsmcr-1 gene expressionProcalcitonin

Beyond the preview

Go deeper on Lipopolysaccharide lipid A phosphate groups.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipopolysaccharide lipid A phosphate groups.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call